Skip to main content

Maraviroc (MVC) increases CD4+ and CD8+ cells: long-term data from the MVC clinical development program

Access & Citations

  • 1084
    Article Accesses
  • 0
    Web of Science
  • 0

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.